What Is a Medicare Donut Hole (Part D Coverage Gap)?


The Medicare donut hole refers to the Part D coverage gap, a coverage phase in the Medicare prescription drug plan. It follows the initial coverage period and begins when you and your plan spend a total of $5,030 on drugs in 2024.

The donut hole technically closed in 2020 thanks to provisions from the Affordable Care Act, so Medicare beneficiaries pay less for drugs in the coverage gap than they previously had to. However, the coverage gap still exists as a coverage phase under Medicare, and you may pay more for your medications than during the initial coverage phase, depending on the structure of your plan benefits.

The Medicare Part D coverage gap will be officially eliminated on January 1, 2025, when provisions from the Inflation Reduction Act regarding maximum out-of-pocket spending take effect.

Table of Contents

What Is the Donut Hole in Medicare Part D (Prescription Coverage)?

The Medicare "donut hole" is a phase in the Medicare Part D benefit structure where the beneficiary may temporarily pay higher out-of-pocket costs for prescription drugs. However, since the donut hole technically closed in 2020, out-of-pocket expenses during the coverage gap are similar to what you pay during the initial coverage period. Previously, Medicare beneficiaries had to pay 100% of drug costs while in the coverage gap.

The so-called coverage gap begins when you reach a certain spending limit on covered drugs (including payments by both you and your plan), which is $5,030 in 2024. This coverage phase continues until you meet the catastrophic coverage threshold ($8,000 for 2024).

During the coverage gap, Medicare beneficiaries pay up to 25% of the cost of generic and brand-name drugs, which may be slightly more than what they paid during the initial coverage period, depending on their benefit structure.

  • Brand-Name Medications in the Donut Hole During the coverage gap phase, Medicare beneficiaries pay no more than 25% of the cost of covered brand-name prescription drugs and 25% of the dispensing fee (usually $1–$3). The manufacturer covers 70% of the drug cost, and your plan covers the remaining 5%. Payments made by the beneficiary and the manufacturer (95% of the drug cost) count towards the out-of-pocket spending to help beneficiaries move towards catastrophic coverage faster, where costs are entirely covered.

  • Generic Medications in the Donut Hole For generic medications, which are cheaper than brand-name drugs, only the beneficiary's payment (25% of the cost) is counted towards out-of-pocket spending in the donut hole as there's no manufacturer discount. Medicare contributions (75% of the cost) are not counted towards the out-of-pocket total, so reaching the catastrophic coverage threshold can take longer.

While the coverage gap is still considered a distinct phase in Medicare Part D coverage, beneficiaries no longer experience a total gap in coverage thanks to the Affordable Care Act. What you pay during the coverage gap and any manufacturer payments for brand-name drugs are counted toward your out-of-pocket limit. Once the limit is reached, you begin catastrophic coverage, where your plan completely covers costs for prescription drugs.

Opting for generic drugs while in the donut hole may mean that it takes longer to reach the catastrophic coverage phase, but you'll still pay less for your prescriptions overall.

Impact of the Inflation Reduction Act on Medicare Part D Benefits and Costs

 

The Inflation Reduction Act has introduced significant changes to Medicare Part D, which directly impact beneficiaries, particularly in managing prescription drug costs.

Fast fact icon

Drug Price Negotiation: Medicare can now negotiate directly with drug manufacturers for some high-cost single-source brand-name drugs in Part B and Part D. This negotiation aims to lower drug prices, making them more accessible and affordable for beneficiaries. The first 10 covered drugs have been selected for negotiation, with negotiated prices becoming effective in 2026.

Fast fact icon

Out-of-Pocket Cap: There will be a cap on annual out-of-pocket prescription drug costs for Medicare beneficiaries starting in 2025. The cap is set at $2,000 for 2025, which will officially eliminate the coverage gap or donut hole — beneficiaries will move straight from the initial coverage phase to catastrophic coverage once they hit the $2,000 limit.

Fast fact icon

Expansion of LIS Program: The low-income subsidy program (LIS or “Extra Help”) under Medicare Part D has expanded as of 2024 to include a larger segment of the low-income population. Individuals with incomes up to 150% of the federal poverty level are now eligible.

Fast fact icon

Insulin Cost Reduction: The Inflation Reduction Act also addresses the high cost of insulin by capping the monthly cost of covered insulin prescriptions at $35, making this vital medication more affordable for diabetic patients.

Fast fact icon

Inflation Rebates: Drug companies must pay rebates to Medicare if their drug prices increase faster than the rate of inflation. This measure aims to control drug price hikes and ensure fair pricing.

How Does the Medicare Donut Hole Work?

The Medicare donut hole is the coverage phase of Medicare Part D that follows the deductible phase and initial coverage period. Each phase is marked by distinct cost-sharing measures. Recent changes from the Affordable Care Act and Inflation Reduction Act have significantly lowered costs for beneficiaries after reaching the donut hole.

  1. Deductible Phase: If your plan has a deductible, you'll begin the year by paying 100% of the cost of covered prescription drugs. The maximum annual deductible for Medicare Part D in 2024 is $545.

  2. Initial Coverage Phase: Once you hit your deductible (or if your plan doesn't have a deductible), you enter the initial coverage phase. During this phase, you'll pay copayments and co-insurance depending on your plan's benefits. This stage lasts until the total expenditure on covered drugs, both by you and your plan, reaches $5,030.

  3. Reaching the Donut Hole: This phase begins when the combined spending on covered drugs by you and your Medicare Part D plan hits the $5,030 mark. The donut hole no longer represents a full coverage gap like it used to before 2020, but it is still a distinct phase in Medicare Part D coverage. You'll pay no more than 25% of the cost of brand-name and generic drugs, which may be similar to what you paid during the initial coverage phase. During this phase, your payments and manufacturer payments towards drug costs count toward your out-of-pocket spending, but payments by your plan do not.

  4. Catastrophic Coverage: Once your out-of-pocket costs hit the $8,000 threshold for 2024, you move out of the donut hole and into the catastrophic coverage phase. The Inflation Reduction Act has eliminated the previous 5% co-insurance requirement, meaning that your drug costs are completely covered for the remainder of the year.

How to Avoid the Medicare Donut Hole

Avoiding the Medicare donut hole is less vital than it once was since beneficiaries still have coverage during this phase as of 2020. However, out-of-pocket costs may still be slightly higher than during the initial coverage period.

With strategic choices and careful planning, and depending on your specific situation and needs, you may be able to avoid hitting this coverage phase. Here are some strategies to potentially avoid the donut hole:

  1. 1

    Understand Your Part D Plan

    Annually review your Medicare Part D plan during the open enrollment period. Focus on the plan's formulary, tiers and any changes in coverage. Choosing a plan that aligns with your prescription needs is crucial for managing costs.

  2. 2

    Go for Generic or Lower-Cost Drugs

    Opt for generic or less expensive brand-name drugs when possible. Generics offer the same efficacy at a significantly lower cost. Discuss the possibility of switching to generics or cost-effective alternatives with your health care provider.

  3. 3

    Use Mail-Order Pharmacies

    Some Part D plans offer savings for buying a 90-day supply of medication through mail-order pharmacies, which can be more economical than purchasing at a retail pharmacy.

  4. 4

    Check for Manufacturer and State Assistance Programs

    Investigate pharmaceutical assistance programs offered by drug manufacturers, especially for costly medications or for those with limited income. Additionally, check for State Pharmaceutical Assistance Programs (SPAPs) in your area that help pay prescription drug costs.

  5. 5

    Apply for Extra Help/Low-Income Subsidy (LIS)

    For those with limited income and resources, Medicare's Extra Help program can reduce Part D costs.Under Extra Help in 2024, you won’t have to pay plan premiums or deductibles.

    Cost Type Price You Pay
    Plan Premium $0
    Plan Deductible $0
    Generic Drug Cost Up to $4.50 per prescription
    Brand-Name Drug Cost Up to $11.20 per prescription
    Catastrophic Coverage $0 for each covered drug
  6. 6

    Monitor Drug Spending

    Keep a close eye on your drug expenses to anticipate approaching the donut hole threshold, enabling better financial planning.

  7. 7

    Medication Therapy Management (MTM) Review

    Request an MTM review if you’re on multiple medications. This can help manage your medications more effectively and identify cost-saving opportunities.

  8. 8

    Manufacturer Coupons and Discount Cards

    For high-cost brand-name drugs, consider using manufacturer coupons or discount cards.

  9. 9

    Regular Prescription Reviews

    Periodically review your prescriptions with your health care provider to ensure all medications are necessary and to explore cheaper alternatives.

FAQ About the Medicare Donut Hole

MoneyGeek has compiled a list of frequently asked questions to clarify key aspects of the Medicare donut hole.

How do you get out of the Medicare donut hole?

Is there any insurance that covers the donut hole?

What is the Medicare donut hole in 2024?

Is the Medicare donut hole going away in 2024?

What happens when you reach the donut hole?

About Mark Fitzpatrick


Mark Fitzpatrick headshot

Mark Fitzpatrick is a Licensed Property and Casualty Insurance Producer and MoneyGeek's Head of Insurance. He has analyzed the insurance market for over five years, conducting original research and creating personalized content for every kind of buyer. He has been quoted in several insurance-related publications, including CNBC, NBC News and Mashable.

Fitzpatrick earned a master’s degree in economics and international relations from Johns Hopkins University and a bachelor’s degree from Boston College. He is passionate about using his knowledge of economics and insurance to bring transparency around financial topics and help others feel confident in their money moves.


sources